Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation.
Coproduction
Equity
Guidance
Guidelines
Integrated knowledge translation
Stakeholder engagement
Systematic reviews
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
01 02 2020
01 02 2020
Historique:
received:
06
08
2019
accepted:
06
01
2020
entrez:
3
2
2020
pubmed:
3
2
2020
medline:
26
1
2021
Statut:
epublish
Résumé
Stakeholder engagement has become widely accepted as a necessary component of guideline development and implementation. While frameworks for developing guidelines express the need for those potentially affected by guideline recommendations to be involved in their development, there is a lack of consensus on how this should be done in practice. Further, there is a lack of guidance on how to equitably and meaningfully engage multiple stakeholders. We aim to develop guidance for the meaningful and equitable engagement of multiple stakeholders in guideline development and implementation. This will be a multi-stage project. The first stage is to conduct a series of four systematic reviews. These will (1) describe existing guidance and methods for stakeholder engagement in guideline development and implementation, (2) characterize barriers and facilitators to stakeholder engagement in guideline development and implementation, (3) explore the impact of stakeholder engagement on guideline development and implementation, and (4) identify issues related to conflicts of interest when engaging multiple stakeholders in guideline development and implementation. We will collaborate with our multiple and diverse stakeholders to develop guidance for multi-stakeholder engagement in guideline development and implementation. We will use the results of the systematic reviews to develop a candidate list of draft guidance recommendations and will seek broad feedback on the draft guidance via an online survey of guideline developers and external stakeholders. An invited group of representatives from all stakeholder groups will discuss the results of the survey at a consensus meeting which will inform the development of the final guidance papers. Our overall goal is to improve the development of guidelines through meaningful and equitable multi-stakeholder engagement, and subsequently to improve health outcomes and reduce inequities in health.
Sections du résumé
BACKGROUND
Stakeholder engagement has become widely accepted as a necessary component of guideline development and implementation. While frameworks for developing guidelines express the need for those potentially affected by guideline recommendations to be involved in their development, there is a lack of consensus on how this should be done in practice. Further, there is a lack of guidance on how to equitably and meaningfully engage multiple stakeholders. We aim to develop guidance for the meaningful and equitable engagement of multiple stakeholders in guideline development and implementation.
METHODS
This will be a multi-stage project. The first stage is to conduct a series of four systematic reviews. These will (1) describe existing guidance and methods for stakeholder engagement in guideline development and implementation, (2) characterize barriers and facilitators to stakeholder engagement in guideline development and implementation, (3) explore the impact of stakeholder engagement on guideline development and implementation, and (4) identify issues related to conflicts of interest when engaging multiple stakeholders in guideline development and implementation.
DISCUSSION
We will collaborate with our multiple and diverse stakeholders to develop guidance for multi-stakeholder engagement in guideline development and implementation. We will use the results of the systematic reviews to develop a candidate list of draft guidance recommendations and will seek broad feedback on the draft guidance via an online survey of guideline developers and external stakeholders. An invited group of representatives from all stakeholder groups will discuss the results of the survey at a consensus meeting which will inform the development of the final guidance papers. Our overall goal is to improve the development of guidelines through meaningful and equitable multi-stakeholder engagement, and subsequently to improve health outcomes and reduce inequities in health.
Identifiants
pubmed: 32007104
doi: 10.1186/s13643-020-1272-5
pii: 10.1186/s13643-020-1272-5
pmc: PMC6995157
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21Subventions
Organisme : Medical Research Council
ID : MRC_UU_12017/15
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRC_UU_12017/13
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00022/2
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU15
Pays : United Kingdom
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : CIHR
ID : FDN 143237
Pays : Canada
Organisme : CIHR
ID : PJT-155970
Pays : Canada
Organisme : Chief Scientist Office
ID : SPHSU13
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU17
Pays : United Kingdom
Références
J Comp Eff Res. 2015 Mar;4(2):133-45
pubmed: 25825842
BMJ Open. 2014 Dec 05;4(12):e005660
pubmed: 25479795
Syst Rev. 2018 Nov 24;7(1):208
pubmed: 30474560
Qual Health Care. 1999 Sep;8(3):177-83
pubmed: 10847875
Gastrointest Endosc. 2015 Mar;81(3):489-501.e26
pubmed: 25708752
J Clin Epidemiol. 2017 Aug;88:102-112
pubmed: 28579379
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
Health Care Manage Rev. 1998 Summer;23(3):30-7
pubmed: 9702559
Implement Sci. 2012 Jul 23;7:67
pubmed: 22824094
J Clin Epidemiol. 2017 Oct;90:68-75
pubmed: 28499847
Eur Respir J. 2017 Mar 22;49(3):
pubmed: 28331043
J Clin Epidemiol. 2017 Jul;87:4-13
pubmed: 28529184
Health Res Policy Syst. 2006 Nov 21;4:13
pubmed: 17118181
Implement Sci. 2016 Sep 20;11(1):126
pubmed: 27647000
Bull World Health Organ. 2006 Aug;84(8):643-51
pubmed: 16917652
CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Int J Qual Health Care. 2016 Feb;28(1):122-8
pubmed: 26796486
Med J Aust. 2015 Oct 5;203(7):283-4
pubmed: 26424059
Am J Public Health. 2010 Apr 1;100 Suppl 1:S40-6
pubmed: 20147663
J Gen Intern Med. 2019 Mar;34(3):458-463
pubmed: 30565151
J Health Serv Res Policy. 2019 Oct;24(4):245-255
pubmed: 30997859
Health Expect. 2015 Oct;18(5):942-55
pubmed: 23634973
J Clin Epidemiol. 2014 Jan;67(1):56-64
pubmed: 24189091
Res Involv Engagem. 2017 Aug 2;3:13
pubmed: 29062538
Implement Sci. 2008 Dec 17;3:54
pubmed: 19091108
Qual Health Res. 2012 Aug;22(8):1126-37
pubmed: 22673090
F1000Res. 2018 Jun 18;7:752
pubmed: 30364075
BMJ. 2017 Jan 16;356:j80
pubmed: 28093384
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
PLoS One. 2015 Apr 07;10(4):e0122246
pubmed: 25849568
Ann Intern Med. 2012 Apr 3;156(7):525-31
pubmed: 22473437
PLoS Med. 2010 Feb 16;7(2):e1000217
pubmed: 20169112
Health Expect. 2017 Feb;20(1):3-10
pubmed: 27115476
Res Involv Engagem. 2018 Oct 22;4:34
pubmed: 30377540
Health Expect. 2008 Mar;11(1):72-84
pubmed: 18275404
Proc Am Thorac Soc. 2012 Dec;9(5):269-73
pubmed: 23256170
Health Res Policy Syst. 2014 Jul 14;12:34
pubmed: 25023520
Res Involv Engagem. 2017 Oct 2;3:19
pubmed: 29062544
J Multidiscip Healthc. 2015 Feb 16;8:101-8
pubmed: 25733912
Bull World Health Organ. 2017 Feb 1;95(2):87
pubmed: 28250505
World Allergy Organ J. 2015 Jan 27;8(1):4
pubmed: 25628773
J Gen Intern Med. 2012 Aug;27(8):985-91
pubmed: 22528615
Int J Health Serv. 1992;22(3):429-45
pubmed: 1644507